You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Major Coronary event

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atherosclerosis Trial in Monaco (18F-Na PET Scan)

Not yet recruiting
  • Atherosclerosis
  • 18F-Na PET Scan
  • Monaco, Monaco
    Centre Hospitalier Princesse Grace
Aug 22, 2023

Cardiovascular Risk Reduction of Having a Coronary Event Trial in Halifax (Minimal Intervention, Motivational Interviewing,

Completed
  • Cardiovascular Risk Reduction of Having a Coronary Event
  • Minimal Intervention
  • +2 more
  • Halifax, Nova Scotia, Canada
    Duffus Health Centre
Nov 10, 2022

Coronary Artery Disease Trial in Isparta (N-acetyl cysteine, Saline)

Active, not recruiting
  • Coronary Artery Disease
  • Isparta, Mediterranean Region, Turkey
    Suleyman Demirel University
Jan 8, 2022

Potentials in Borderline Personality Disorder and Major

Terminated
  • Borderline Personality Disorder
  • Major Depression
    • Syracuse, New York
    • +1 more
    May 14, 2021

    Diabetes, Type 2, Coronary Artery Disease Trial in Jacksonville (Ticagrelor, Clopidogrel)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Coronary Artery Disease
    • Jacksonville, Florida
      University of Florida
    Nov 2, 2021

    Coronary Computed Tomography Angiography, Stable Chest Pain, Optimal Medical Therapy Trial in Beijing, Tianjin (CCTA)

    Recruiting
    • Coronary Computed Tomography Angiography
    • +6 more
    • CCTA
    • Beijing, China
    • +1 more
    Feb 21, 2022

    Acute ST Segment Elevation Myocardial Infarction Trial in Isparta (NAC, Saline)

    Active, not recruiting
    • Acute ST Segment Elevation Myocardial Infarction
    • Isparta, Mediterranean Region, Turkey
      Suleyman Demirel University
    Jan 8, 2022

    Diabetes, Coronary Artery Disease, Coronary Atheroscleroses Trial in Zwolle (Optical Coherence Tomography)

    Completed
    • Diabetes Mellitus
    • +2 more
    • Optical Coherence Tomography
    • Zwolle, Overijssel, Netherlands
      Isala
    Aug 30, 2021

    Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)

    Not yet recruiting
    • Primary Prevention of Atherosclerotic Cardiovascular Disease
    • Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
    • Placebo in 1.5ml
    • (no location specified)
    Feb 13, 2023

    Diabetes, Acute Coronary Syndrome, Coronary Artery Disease Trial in Paris (Novel strategy Aspirin, Conventional strategy

    Active, not recruiting
    • Diabetes Mellitus
    • +3 more
    • Novel strategy Aspirin
    • Conventional strategy Aspirin
    • Paris, France
      Department of Cardiology - Lariboisiere Hospital
    Jan 2, 2023

    Tricuspid Valve Regurgitation Trial (Transcatheter edge-to-edge repair (TEER))

    Not yet recruiting
    • Tricuspid Valve Regurgitation
    • Transcatheter edge-to-edge repair (TEER)
    • (no location specified)
    Oct 10, 2022

    Obstructive Hypertrophic Cardiomyopathy

    Completed
    • Microvascular Dysfunction
    • +2 more
      • Beijing, Beijing, China
        Fuwai Hospital, China National Center for Cardiovascular Disease
      Jan 11, 2023

      Bleeding and Ischemic Risk

      Completed
      • Coronary Artery Disease
      • Percutaneous Coronary Intervention
      • Percutaneous coronary intervention
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Oct 13, 2023

      Impact of COVID-19 Vaccines on Cerebrovascular Health

      Recruiting
      • Stroke
      • +9 more
      • Laboratory tests and Montreal Cognitive Assessment
      • Hong Kong, Hong Kong
        Chinese University of Hong Kong
      Mar 7, 2022

      Low-density Lipoprotein Cholesterol Reduction With

      Recruiting
      • Acute Coronary Syndrome
      • Dyslipidemias
      • Banja Luka, Republic Of Srpska, Bosnia and Herzegovina
        University Clinical Centre of the Republic of Srpska
      Oct 17, 2021

      Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)

      Not yet recruiting
      • Arteriosclerosis
      • Hypercholesterolaemia
      • (no location specified)
      Aug 17, 2023

      Risk Factors for Predictors of MACEs After RA-CABG

      Completed
      • Coronary Artery Disease
        • Shanghai, Shanghai, China
          Ruijin Hospital Shanghai Jiao Tong University School of Medicine
        Nov 30, 2021

        Risk Factors and Outcomes in Coronary Chronic Total Occlusion

        Recruiting
        • Chronic Total Occlusion
        • Coronary Artery Disease
        • Coronary angiography
        • Shanghai, China
          Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
        Nov 13, 2023

        Atherosclerotic Cardiovascular Disease Trial in Oxford (Anacetrapib, Placebo anacetrapib)

        Active, not recruiting
        Has Results
        • Atherosclerotic Cardiovascular Disease
        • Oxford, Oxfordshire, United Kingdom
          CTSU, University of Oxford
        Mar 1, 2022

        Coronary Artery Stenosis Trial in Seoul (State-of-the-Art Percutaneous Coronary Intervention, standard CABG)

        Not yet recruiting
        • Coronary Artery Stenosis
        • State-of-the-Art Percutaneous Coronary Intervention
        • standard CABG
        • Seoul, Korea, Republic of
          Asan Medical Center
        Apr 14, 2023

        Patient With Anterior Myocardial Infarction Trial in Sohag (-group of patients(75 patients) will receive low dose rivaroxaban

        Not yet recruiting
        • Patient With Anterior Myocardial Infarction
        • -group of patients(75 patients) will receive low dose rivaroxaban myocardial infarction plus (acetylsalicylic acid 75 mg and clopidogrel 75 mg
        • (acetylsalicylic acid 75 mg once daily orally and clopidogrel 75 mg once daily orally only)
        • Sohag, Egypt
          Sohag University Hospital
        Feb 16, 2023

        Coronary Artery Disease Trial in Seoul (Clopidogrel treatment group, No antiplatelet or anticoagulant group)

        Recruiting
        • Coronary Artery Disease
        • Clopidogrel treatment group
        • No antiplatelet or anticoagulant group
        • Seoul, Other, Korea, Republic of
          Seoul National University Hospital
        May 9, 2023

        Common Femoral Artery Injury, Other Vascular Adverse Event Trial in Assiut (Assiut Femoral Compression Device)

        Withdrawn
        • Common Femoral Artery Injury
        • Other Vascular Adverse Event
        • Assiut Femoral Compression Device
        • Assiut, Egypt
          Assiut University Hospitals
        Jul 14, 2021

        Quality of Life After Cardiac Surgery

        Recruiting
        • Aortic Valve Stenosis
        • +4 more
        • Cardiac Surgery
        • Cambridge, Cambridgeshire, United Kingdom
          Royal Papworth Hospital
        Oct 2, 2022

        PARA-HEART Pilot Implementation

        Completed
        • Acute Coronary Syndrome
        • Chest Pain
          • Winston-Salem, North Carolina
            Wake Forest School Of Medicine
          Mar 3, 2022